BELLAN CRISTIANA

Teaching activities

Completion accademic year: 2022/2023

Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2020/2021
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2020/2021
Course year: 1 Full cicle (6 years) DENTISTRY AND DENTAL PROSTHODONTICS A.Y. 2022/2023
Course year: 2 Full cicle (6 years) DENTISTRY AND DENTAL PROSTHODONTICS A.Y. 2021/2022
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2019/2020
Course year: 1 First cycle degree (DM 270) SPEECH AND LANGUAGE THERAPY A.Y. 2022/2023
Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2019/2020

Completion accademic year: 2021/2022

Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2019/2020

Research

Ultime pubblicazioni:

  • Barbarino, M., Bottaro, M., Spagnoletti, L., de Santi, M.M., Guazzo, R., Defraia, C., et al. (2022). Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology. CANCERS, 14(21), 5216 [10.3390/cancers14215216]. - view more
  • Spini, A., Rosellini, P., Bellan, C., Furiesi, F., Giorgi, S., Donnini, S., et al. (2022). Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry. PLOS ONE, 17(6), 1-10 [10.1371/journal.pone.0269232]. - view more
  • Volterrani, L., Guerrini, S., Zanfrini, E., Grassi, A., Addamo, E., Mathieu, F., et al. (2022). “HRCT predictors of GGO surgical resection: Histopathological and molecular correlation in the era of lung sparing surgery”. LUNG CANCER, 166, 70-75 [10.1016/j.lungcan.2022.02.001]. - view more
  • Cersosimo, F., Barbarino, M., Lonardi, S., Vermi, W., Giordano, A., Bellan, C., et al. (2021). Mesothelioma malignancy and the microenvironment: Molecular mechanisms. CANCERS, 13(22), 1-20 [10.3390/cancers13225664]. - view more
  • Spini, A., Gini, R., Rosellini, P., Singier, A., Bellan, C., Pascucci, A., et al. (2021). First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: A real-life setting study with gender prospective. CANCERS, 13(23), 6129 [10.3390/cancers13236129]. - view more